《中国心血管健康与疾病报告2022》要点解读

ue to the acceleration of population aging and the prevalence of unhealthy lifestylesthe huge population with cardiovascular diseaseCVD risk factorsthe burden of CVD continues to increase in China. CVD is still the leading cause of death among urban and rural residents in China. In 2020CVD accounted for 48.00% and 45.86% of the causes of death in rural and urban areasrespectivelyand two out of every five deaths were due to CVD. It is estimated that the number of current CVD patients in China is 330 millionincluding 13 million cases of stroke11.39 million cases of coronary heart disease8.9 million cases of heart failure5 million cases of pulmonary heart disease4.87 million cases of atrial fibrillation2.5 million cases of rheumatic heart disease2 million cases of congenital heart disease45.3 million cases of peripheral artery diseaseand 245 million cases of hypertension. The total hospitalization costs were 270.901 billion yuan for CVD in China in 2020. The prevention and treatment of CVD in China still has a long way to go. In generalwe should not only do a good job in secondary prevention and treatment of CVDbut also further strengthen the upstream treatment of modifiable risk factors such as hypertensionhyperglycemia and hyperlipidemia starting with both preventive treatment and treatment diseases. In additionattention should be paid to the allocation and prioritization of health care and public health resourcesso as to reach the inflection point of CVD prevention and treatment as early as possible.